Collaboration and cross-selling across Syneos Health's clinical and commercial organizations drove a record quarter marked by new strategic relationships as customers look to increase outsourcing in response to pricing pressures.
Regulatory eyes on Regeneron: US FDA issues CRL for Eylea
from BioPharma-Reporter.com
ABL Bio and I-Mab Biopharma ink bispecific antibody deal
from BioPharma-Reporter.com
Lexaira Bioscience demonstrates high bioavailability in CBD platform
from in-PharmaTechnologist.com
Artios Pharma raises $84m in Series B financing
from in-PharmaTechnologist.com
Robotics, automation to play a ‘fundamental role’ in Icon’s continued success: Q2 earnings call
Clinical evolution
Jerusalem’s Hadassah Medical Center joins TriNetX network
Globalization
PSI CRO continues growth in Asia-Pacific
Globalization
EMA pulls back on activity, with 30%+ staff losses expected
Globalization
